See more : Sumber Mineral Global Abadi Tbk (SMGA.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Berkeley Lights, Inc. (BLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Berkeley Lights, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- KushCo Holdings, Inc. (KSHB) Income Statement Analysis – Financial Results
- Objective Corporation Limited (OCL.AX) Income Statement Analysis – Financial Results
- AI/ML Innovations Inc. (AIMLF) Income Statement Analysis – Financial Results
- Guangxi Nanning Waterworks Co.,Ltd. (601368.SS) Income Statement Analysis – Financial Results
- Grindrod Shipping Holdings Ltd. (GRIN) Income Statement Analysis – Financial Results
Berkeley Lights, Inc. (BLI)
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 78.60M | 85.39M | 64.30M | 56.69M | 31.30M |
| Cost of Revenue | 24.81M | 28.84M | 19.75M | 13.22M | 8.18M |
| Gross Profit | 53.78M | 56.55M | 44.56M | 43.48M | 23.12M |
| Gross Profit Ratio | 68.43% | 66.23% | 69.29% | 76.69% | 73.86% |
| Research & Development | 53.21M | 58.55M | 47.24M | 38.41M | 29.08M |
| General & Administrative | 0.00 | 43.40M | 23.20M | 12.36M | 9.07M |
| Selling & Marketing | 0.00 | 25.39M | 14.51M | 9.24M | 6.13M |
| SG&A | 95.12M | 68.79M | 37.71M | 21.60M | 15.20M |
| Other Expenses | -246.00K | 6.00K | 82.00K | -1.18M | 0.00 |
| Operating Expenses | 148.32M | 127.34M | 84.95M | 60.01M | 44.28M |
| Cost & Expenses | 173.14M | 156.18M | 104.70M | 73.23M | 52.46M |
| Interest Income | 1.27M | 175.00K | 338.00K | 909.00K | 872.00K |
| Interest Expense | 910.00K | 1.17M | 1.44M | 1.43M | 2.20M |
| Depreciation & Amortization | 1.02M | 181.00K | 420.00K | 6.24M | 4.29M |
| EBITDA | -93.52M | -70.61M | -39.97M | -10.29M | -16.87M |
| EBITDA Ratio | -118.99% | -82.69% | -62.17% | -18.16% | -53.89% |
| Operating Income | -94.54M | -70.79M | -40.39M | -16.54M | -21.16M |
| Operating Income Ratio | -120.29% | -82.90% | -62.82% | -29.17% | -67.60% |
| Total Other Income/Expenses | -3.40M | -990.00K | -1.02M | -1.70M | -2.11M |
| Income Before Tax | -97.94M | -71.78M | -41.41M | -18.23M | -23.27M |
| Income Before Tax Ratio | -124.61% | -84.06% | -64.40% | -32.16% | -74.34% |
| Income Tax Expense | 100.00K | -55.00K | 174.00K | 69.00K | 69.00K |
| Net Income | -98.04M | -71.72M | -41.58M | -18.30M | -23.34M |
| Net Income Ratio | -124.74% | -84.00% | -64.67% | -32.28% | -74.56% |
| EPS | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| EPS Diluted | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
| Weighted Avg Shares Out | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
| Weighted Avg Shares Out (Dil) | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022
EMERYVILLE, Calif. , Oct. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the third quarter 2022 after market on Tuesday, November 8, 2022.
Berkeley Lights to Participate in the BioProcess International 2022 Conference
Company to present on its Bispecifics Heterodimer Assay and Custom Productivity Assay for the Opto ® Cell Line Development workflow GSK Vaccines, Rockville to present on their successful implementation of the Berkeley Lights' Beacon ® technology for accelerated cell line...
Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer
EMERYVILLE, Calif. , Sept. 19, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal officer and corporate secretary, effective immediately.
Berkeley Lights, Inc. (BLI) CEO Siddhartha Kadia on Q2 2022 Results - Earnings Call Transcript
Berkeley Lights, Inc. (NASDAQ:BLI ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Suzanne Hatcher - Vice President, Communications & Investor Relations Siddhartha Kadia - Chief Executive Officer Mehul Joshi - Chief Financial Officer Lucas...
Berkeley Lights Reports Second Quarter 2022 Financial Results
Company outlines near-term strategic plan to generate positive operating cashflow by early 2025 EMERYVILLE, Calif. , Aug. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended...
Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen
EMERYVILLE, Calif. , Aug. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today announced the discovery, functional characterization, and recovery of a patient-derived...
Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference
Presentation to feature the Company's soon-to-be launched bispecific and custom productivity assay for the Opto® Cell Line Development workflow EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation...
Berkeley Lights Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development
EMERYVILLE, Calif. , Aug. 1, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Rolando Brawer, Ph.D.
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide
Using Berkeley Lights' high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE, Calif. , July 27, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in...
Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer
EMERYVILLE, Calif. , July 25, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately.
Source: https://incomestatements.info
Category: Stock Reports